What we are doing is making novel tests to help support doctors and patients in the area of women’s health, said Dr. Jessica Richman, CEO and Co-founder of uBiome
SAN FRANCISCO (PRWEB)
November 14, 2017
UBIOME LAUNCHES SMARTJANE™—
REVOLUTIONARY TEST FOR WOMEN’S HEALTH THAT COMBINES HPV, STIs, AND VAGINAL RISK FACTORS
TO GET YOU THE ANSWERS YOU NEED
uBiome’s Combined HPV, STI, and Vaginal Risk Factors Test Lets You Test at Home — And It’s Covered by Health Insurance
uBiome, the leader in microbial genomics, launches SmartJane™— the first sequencing-based at-home women’s health test. SmartJane™ is the first test to combine human papillomavirus (HPV) genotyping, sexually transmitted infections (STI) testing, and microbial risk factors for HPV infection, bacterial vaginosis, cervicitis, idiopathic infertility, pelvic inflammatory disease, bacterial vaginosis, and aerobic vaginitis. Patients can sample in the comfort of their own home. The test is not intended to replace traditional Pap smears or well woman visits. SmartJane™ is only available with a valid lab test order from a healthcare provider.
SmartJane™ can tell doctors and patients which type of HPV strain they have (genotyping), and how the microbiome interacts with HPV to increase or decrease risk. SmartJane tests for 14 high-risk HPV types which are associated with cervical cancer, squamous intraepithelial lesions, and cervicitis. SmartJane also tests for 5 low-risk HPV strains.
In a combined approach, SmartJane™ tests for three common STIs as well as HPV and vaginal flora balance: Chlamydia trachomatis (chlamydia), Neisseria gonorrhoeae (gonorrhea), and Mycoplasma genitalium. Mycoplasma genitalium is a common STI that can be a cause of unexplained infertility. This bacterium has been recently…
Read the full article from the Source…